Ingenico Group (Euronext: FR0000125346 – ING), the global leader in seamless payment, has partnered with Newpharma, the Belgian e-pharmacy business, to deliver a payment experience that meets the security needs of online pharmaceutical buyers and supports its ambitious growth plans.
Newpharma was established in 2008 with the ultimate goal of bringing the pharmacy industry online – and transforming one of the world’s oldest professions. Four months after its first sale, Newpharma received authorization to sell non-prescription medication online. Now non-prescription medication accounts for 15% of Newpharma sales, with a large proportion of those sales coming from France and the Netherlands.
With much demand coming from beyond its domestic market – and due to the potentially sensitive nature of e-pharmacy purchases – Newpharma required a payments provider that could promise flawless processing of international sales and the protection of personal information.
Ingenico ePayments’ platform allows Newpharma to tailor the payment experience to the requirements of international markets, including language, currency and preferred payment method. This guarantees an easy-to-use, secure and smooth checkout process for customers, which ultimately reduces basket abandonment rates and protects consumer data.
Commenting on the partnership, Jérôme Gobbesso, CEO of Newpharma, said: “Because the pharmacy sector is the most demanding in terms of customer requirements, it is essential for us to have a stable and secure platform. And that is what we have managed to put in place thanks to Ingenico ePayments.
“We are very happy with our payment partner, although most of the time we don’t need to think about it since everything works as it should, without a glitch.”
Benoit Boudier, Managing Director, SMB Online Europe at Ingenico ePayments, added: “We are thrilled to support Newpharma’s rapid development. Data security is particularly important to Newpharma customers, so we’re pleased to give them peace of mind when shopping online by providing a secure, PSD2-compliant payment environment powered by the trusted Ingenico brand.”
With ambitious plans of revolutionizing the pharmaceutical industry, Newpharma has already experienced exponential growth and had to relocate three times and expand twice in just eight years.
For more on Newpharma’s business journey and how Ingenico has supported its rapid growth, take a look at the My Business, My Story video case study here.
About Ingenico Group
Ingenico Group (Euronext: FR0000125346 – ING) is the global leader in seamless payment, providing smart, trusted and secure solutions to empower commerce across all channels, in-store, online and mobile. With the world’s largest payment acceptance network, we deliver secure payment solutions with a local, national and international scope. We are the trusted world-class partner for financial institutions and retailers, from small merchants to several of the world’s best known global brands. Our solutions enable merchants to simplify payment and deliver their brand promise.
Stay in touch with us:
For more experts’ views, visit our blog.
Newpharma was launched in Belgium in 2008, expanding its range to offer non-prescription medication in 2009. Today it sells over 37,000 products and is accredited by the FAMHP (Federal Agency for Medicines and Health Products). Its exponential growth has already forced the company to relocate three times and expand twice in just eight years.
Media Contact / Ingenico
(T): +44 330 043 1315